nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.156	0.253	CbGbCtD
Tranexamic Acid—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.139	0.225	CbGbCtD
Tranexamic Acid—SLC15A2—Ramipril—type 2 diabetes mellitus	0.124	0.201	CbGbCtD
Tranexamic Acid—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.118	0.192	CbGbCtD
Tranexamic Acid—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0798	0.129	CbGbCtD
Tranexamic Acid—PLG—tunica intima—type 2 diabetes mellitus	0.0287	0.402	CbGeAlD
Tranexamic Acid—PLG—artery—type 2 diabetes mellitus	0.00981	0.138	CbGeAlD
Tranexamic Acid—PLG—endothelium—type 2 diabetes mellitus	0.00829	0.116	CbGeAlD
Tranexamic Acid—PLG—retina—type 2 diabetes mellitus	0.00403	0.0565	CbGeAlD
Tranexamic Acid—PLG—nephron tubule—type 2 diabetes mellitus	0.0038	0.0532	CbGeAlD
Tranexamic Acid—PLG—cardiovascular system—type 2 diabetes mellitus	0.00341	0.0478	CbGeAlD
Tranexamic Acid—PLG—kidney—type 2 diabetes mellitus	0.00334	0.0468	CbGeAlD
Tranexamic Acid—PLG—cortex of kidney—type 2 diabetes mellitus	0.00325	0.0456	CbGeAlD
Tranexamic Acid—PLG—liver—type 2 diabetes mellitus	0.00211	0.0296	CbGeAlD
Tranexamic Acid—SLC15A2—retina—type 2 diabetes mellitus	0.00129	0.0181	CbGeAlD
Tranexamic Acid—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.00121	0.017	CbGeAlD
Tranexamic Acid—SLC15A2—kidney—type 2 diabetes mellitus	0.00107	0.015	CbGeAlD
Tranexamic Acid—SLC15A2—cortex of kidney—type 2 diabetes mellitus	0.00104	0.0146	CbGeAlD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—TNF—type 2 diabetes mellitus	0.000251	0.00196	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.00025	0.00195	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000248	0.00194	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—RASGRP1—type 2 diabetes mellitus	0.000247	0.00193	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—TNF—type 2 diabetes mellitus	0.000247	0.00193	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—RELA—type 2 diabetes mellitus	0.000244	0.0019	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—TIMP1—type 2 diabetes mellitus	0.000238	0.00186	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—PTGS2—type 2 diabetes mellitus	0.000237	0.00185	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ATP2A3—type 2 diabetes mellitus	0.000232	0.00181	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.00023	0.00179	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.00023	0.00179	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—ADCY5—type 2 diabetes mellitus	0.000226	0.00176	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SOD1—type 2 diabetes mellitus	0.000224	0.00175	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000221	0.00173	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000221	0.00173	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CASP3—type 2 diabetes mellitus	0.000218	0.0017	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000217	0.0017	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—GNB3—type 2 diabetes mellitus	0.000217	0.00169	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IGF2—type 2 diabetes mellitus	0.000213	0.00166	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000211	0.00165	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—DPP4—type 2 diabetes mellitus	0.000209	0.00163	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—SLC30A8—type 2 diabetes mellitus	0.000209	0.00163	CbGpPWpGaD
Tranexamic Acid—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000209	0.00113	CcSEcCtD
Tranexamic Acid—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000208	0.00113	CcSEcCtD
Tranexamic Acid—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000208	0.00113	CcSEcCtD
Tranexamic Acid—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000208	0.00113	CcSEcCtD
Tranexamic Acid—Angiopathy—Metformin—type 2 diabetes mellitus	0.000208	0.00113	CcSEcCtD
Tranexamic Acid—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000207	0.00113	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000207	0.00113	CcSEcCtD
Tranexamic Acid—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000207	0.00112	CcSEcCtD
Tranexamic Acid—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000207	0.00112	CcSEcCtD
Tranexamic Acid—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000206	0.00112	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000206	0.00112	CcSEcCtD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—MMP9—type 2 diabetes mellitus	0.000206	0.00161	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—NFKB1—type 2 diabetes mellitus	0.000205	0.00161	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000204	0.00111	CcSEcCtD
Tranexamic Acid—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000204	0.00111	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000204	0.00159	CbGpPWpGaD
Tranexamic Acid—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000203	0.0011	CcSEcCtD
Tranexamic Acid—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000203	0.0011	CcSEcCtD
Tranexamic Acid—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000203	0.0011	CcSEcCtD
Tranexamic Acid—Hypotension—Glyburide—type 2 diabetes mellitus	0.000202	0.0011	CcSEcCtD
Tranexamic Acid—Nausea—Repaglinide—type 2 diabetes mellitus	0.000202	0.0011	CcSEcCtD
Tranexamic Acid—Asthenia—Glipizide—type 2 diabetes mellitus	0.000202	0.0011	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—type 2 diabetes mellitus	0.000201	0.00157	CbGpPWpGaD
Tranexamic Acid—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000201	0.00109	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—TNF—type 2 diabetes mellitus	0.000201	0.00157	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—GIP—type 2 diabetes mellitus	0.000201	0.00157	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000201	0.00157	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.0002	0.00109	CcSEcCtD
Tranexamic Acid—Flushing—Irbesartan—type 2 diabetes mellitus	0.0002	0.00109	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.0002	0.00109	CcSEcCtD
Tranexamic Acid—Discomfort—Gliclazide—type 2 diabetes mellitus	0.0002	0.00109	CcSEcCtD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL6—type 2 diabetes mellitus	0.0002	0.00156	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000198	0.00108	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—IRS2—type 2 diabetes mellitus	0.000197	0.00154	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—THBD—type 2 diabetes mellitus	0.000197	0.00154	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000197	0.00107	CcSEcCtD
Tranexamic Acid—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000196	0.00106	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000195	0.00106	CcSEcCtD
Tranexamic Acid—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000195	0.00106	CcSEcCtD
Tranexamic Acid—Malaise—Orlistat—type 2 diabetes mellitus	0.000195	0.00106	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000195	0.00106	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—PCSK1—type 2 diabetes mellitus	0.000194	0.00152	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—CALM1—type 2 diabetes mellitus	0.000194	0.00151	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000194	0.00105	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000193	0.00105	CcSEcCtD
Tranexamic Acid—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000193	0.00105	CcSEcCtD
Tranexamic Acid—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000193	0.00105	CcSEcCtD
Tranexamic Acid—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000193	0.00105	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000193	0.00105	CcSEcCtD
Tranexamic Acid—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000192	0.00105	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000192	0.00104	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—type 2 diabetes mellitus	0.000192	0.0015	CbGpPWpGaD
Tranexamic Acid—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000191	0.00104	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000191	0.00104	CcSEcCtD
Tranexamic Acid—Renal failure—Ramipril—type 2 diabetes mellitus	0.000191	0.00104	CcSEcCtD
Tranexamic Acid—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000191	0.00104	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00019	0.00104	CcSEcCtD
Tranexamic Acid—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00019	0.00103	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.00019	0.00103	CcSEcCtD
Tranexamic Acid—Flushing—Losartan—type 2 diabetes mellitus	0.000189	0.00102	CcSEcCtD
Tranexamic Acid—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000188	0.00102	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000188	0.00147	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	0.000188	0.00147	CbGpPWpGaD
Tranexamic Acid—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000188	0.00102	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—CD36—type 2 diabetes mellitus	0.000187	0.00146	CbGpPWpGaD
Tranexamic Acid—Convulsion—Orlistat—type 2 diabetes mellitus	0.000187	0.00102	CcSEcCtD
Tranexamic Acid—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000187	0.00102	CcSEcCtD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—AKT1—type 2 diabetes mellitus	0.000187	0.00146	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000187	0.00101	CcSEcCtD
Tranexamic Acid—Chest pain—Valsartan—type 2 diabetes mellitus	0.000186	0.00101	CcSEcCtD
Tranexamic Acid—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000186	0.00101	CcSEcCtD
Tranexamic Acid—Myalgia—Valsartan—type 2 diabetes mellitus	0.000186	0.00101	CcSEcCtD
Tranexamic Acid—Dizziness—Glipizide—type 2 diabetes mellitus	0.000186	0.00101	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP3—type 2 diabetes mellitus	0.000185	0.00145	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000185	0.001	CcSEcCtD
Tranexamic Acid—PLG—Platelet degranulation—TGFB1—type 2 diabetes mellitus	0.000185	0.00144	CbGpPWpGaD
Tranexamic Acid—Angiopathy—Losartan—type 2 diabetes mellitus	0.000184	0.001	CcSEcCtD
Tranexamic Acid—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000184	0.001	CcSEcCtD
Tranexamic Acid—Chest pain—Orlistat—type 2 diabetes mellitus	0.000184	0.001	CcSEcCtD
Tranexamic Acid—Myalgia—Orlistat—type 2 diabetes mellitus	0.000184	0.001	CcSEcCtD
Tranexamic Acid—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000182	0.000989	CcSEcCtD
Tranexamic Acid—Discomfort—Orlistat—type 2 diabetes mellitus	0.000182	0.000988	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000182	0.00142	CbGpPWpGaD
Tranexamic Acid—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000182	0.000986	CcSEcCtD
Tranexamic Acid—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000181	0.000986	CcSEcCtD
Tranexamic Acid—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000181	0.000982	CcSEcCtD
Tranexamic Acid—Malaise—Metformin—type 2 diabetes mellitus	0.00018	0.000976	CcSEcCtD
Tranexamic Acid—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000179	0.000975	CcSEcCtD
Tranexamic Acid—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000179	0.000972	CcSEcCtD
Tranexamic Acid—Vomiting—Glipizide—type 2 diabetes mellitus	0.000179	0.000971	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000178	0.00097	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000178	0.000969	CcSEcCtD
Tranexamic Acid—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000178	0.000968	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000177	0.000962	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000177	0.000961	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000176	0.000958	CcSEcCtD
Tranexamic Acid—Headache—Glipizide—type 2 diabetes mellitus	0.000176	0.000957	CcSEcCtD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—TGFB1—type 2 diabetes mellitus	0.000176	0.00137	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000175	0.000951	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000175	0.000951	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000174	0.000947	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000174	0.00136	CbGpPWpGaD
Tranexamic Acid—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000174	0.000944	CcSEcCtD
Tranexamic Acid—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000173	0.000943	CcSEcCtD
Tranexamic Acid—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000173	0.000941	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000173	0.00094	CcSEcCtD
Tranexamic Acid—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000173	0.00094	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—IRS1—type 2 diabetes mellitus	0.000172	0.00135	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.000171	0.00134	CbGpPWpGaD
Tranexamic Acid—Back pain—Losartan—type 2 diabetes mellitus	0.000171	0.00093	CcSEcCtD
Tranexamic Acid—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000171	0.000929	CcSEcCtD
Tranexamic Acid—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000171	0.000929	CcSEcCtD
Tranexamic Acid—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00017	0.000924	CcSEcCtD
Tranexamic Acid—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00017	0.000923	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.00017	0.00133	CbGpPWpGaD
Tranexamic Acid—Chest pain—Metformin—type 2 diabetes mellitus	0.00017	0.000921	CcSEcCtD
Tranexamic Acid—Myalgia—Metformin—type 2 diabetes mellitus	0.00017	0.000921	CcSEcCtD
Tranexamic Acid—Malaise—Irbesartan—type 2 diabetes mellitus	0.000169	0.000921	CcSEcCtD
Tranexamic Acid—Headache—Pioglitazone—type 2 diabetes mellitus	0.000169	0.000917	CcSEcCtD
Tranexamic Acid—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000168	0.000912	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000168	0.000911	CcSEcCtD
Tranexamic Acid—Discomfort—Metformin—type 2 diabetes mellitus	0.000167	0.00091	CcSEcCtD
Tranexamic Acid—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000167	0.00091	CcSEcCtD
Tranexamic Acid—Nausea—Glipizide—type 2 diabetes mellitus	0.000167	0.000907	CcSEcCtD
Tranexamic Acid—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000167	0.000906	CcSEcCtD
Tranexamic Acid—Hypotension—Valsartan—type 2 diabetes mellitus	0.000167	0.000906	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—ATP2A2—type 2 diabetes mellitus	0.000167	0.0013	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000167	0.0013	CbGpPWpGaD
Tranexamic Acid—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000166	0.000903	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—CALM1—type 2 diabetes mellitus	0.000166	0.0013	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000165	0.000898	CcSEcCtD
Tranexamic Acid—Headache—Glimepiride—type 2 diabetes mellitus	0.000164	0.000893	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000164	0.000892	CcSEcCtD
Tranexamic Acid—Headache—Sitagliptin—type 2 diabetes mellitus	0.000164	0.00089	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—APOA1—type 2 diabetes mellitus	0.000163	0.00128	CbGpPWpGaD
Tranexamic Acid—Anaemia—Losartan—type 2 diabetes mellitus	0.000163	0.000888	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000163	0.000884	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—IL6—type 2 diabetes mellitus	0.000162	0.00127	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000162	0.00127	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000162	0.00088	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—TRPC6—type 2 diabetes mellitus	0.000162	0.00126	CbGpPWpGaD
Tranexamic Acid—Flushing—Ramipril—type 2 diabetes mellitus	0.000162	0.000879	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000161	0.00126	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000161	0.00126	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000161	0.000873	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00016	0.00087	CcSEcCtD
Tranexamic Acid—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00016	0.000869	CcSEcCtD
Tranexamic Acid—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00016	0.000869	CcSEcCtD
Tranexamic Acid—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00016	0.000869	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—TNF—type 2 diabetes mellitus	0.00016	0.00125	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—AKT2—type 2 diabetes mellitus	0.000159	0.00125	CbGpPWpGaD
Tranexamic Acid—Malaise—Losartan—type 2 diabetes mellitus	0.000159	0.000867	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000159	0.000866	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000159	0.000866	CcSEcCtD
Tranexamic Acid—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000159	0.000865	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—F7—type 2 diabetes mellitus	0.000159	0.00124	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000159	0.000863	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000158	0.00124	CbGpPWpGaD
Tranexamic Acid—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000158	0.000859	CcSEcCtD
Tranexamic Acid—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000157	0.000855	CcSEcCtD
Tranexamic Acid—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000157	0.000854	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000157	0.000853	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000157	0.00122	CbGpPWpGaD
Tranexamic Acid—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000156	0.00085	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PRKCB—type 2 diabetes mellitus	0.000156	0.00122	CbGpPWpGaD
Tranexamic Acid—Nausea—Glimepiride—type 2 diabetes mellitus	0.000156	0.000847	CcSEcCtD
Tranexamic Acid—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000156	0.000846	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000155	0.000845	CcSEcCtD
Tranexamic Acid—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000155	0.000844	CcSEcCtD
Tranexamic Acid—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000155	0.000844	CcSEcCtD
Tranexamic Acid—Asthenia—Glyburide—type 2 diabetes mellitus	0.000155	0.000843	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000154	0.000837	CcSEcCtD
Tranexamic Acid—Fatigue—Valsartan—type 2 diabetes mellitus	0.000154	0.000836	CcSEcCtD
Tranexamic Acid—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000154	0.000834	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000153	0.000833	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000152	0.000827	CcSEcCtD
Tranexamic Acid—Fatigue—Orlistat—type 2 diabetes mellitus	0.000152	0.000826	CcSEcCtD
Tranexamic Acid—Hypotension—Metformin—type 2 diabetes mellitus	0.000152	0.000825	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000151	0.00118	CbGpPWpGaD
Tranexamic Acid—Arthralgia—Losartan—type 2 diabetes mellitus	0.000151	0.000818	CcSEcCtD
Tranexamic Acid—Myalgia—Losartan—type 2 diabetes mellitus	0.000151	0.000818	CcSEcCtD
Tranexamic Acid—Chest pain—Losartan—type 2 diabetes mellitus	0.000151	0.000818	CcSEcCtD
Tranexamic Acid—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00015	0.000818	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00015	0.000817	CcSEcCtD
Tranexamic Acid—Discomfort—Losartan—type 2 diabetes mellitus	0.000149	0.000808	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP1—type 2 diabetes mellitus	0.000148	0.00116	CbGpPWpGaD
Tranexamic Acid—Headache—Bromocriptine—type 2 diabetes mellitus	0.000148	0.000806	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000148	0.000805	CcSEcCtD
Tranexamic Acid—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000148	0.000804	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000147	0.00115	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000146	0.000793	CcSEcCtD
Tranexamic Acid—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000146	0.000792	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000145	0.00079	CcSEcCtD
Tranexamic Acid—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000145	0.000787	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3R1—type 2 diabetes mellitus	0.000145	0.00113	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—AKT1—type 2 diabetes mellitus	0.000145	0.00113	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000144	0.000784	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000144	0.00113	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000144	0.00113	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000144	0.000784	CcSEcCtD
Tranexamic Acid—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000143	0.000779	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000143	0.000778	CcSEcCtD
Tranexamic Acid—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000143	0.000777	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—ADRA2A—type 2 diabetes mellitus	0.000142	0.00111	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TIMP1—type 2 diabetes mellitus	0.000142	0.00111	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PLAT—type 2 diabetes mellitus	0.000142	0.00111	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000142	0.000769	CcSEcCtD
Tranexamic Acid—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000141	0.000767	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000141	0.0011	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000141	0.000765	CcSEcCtD
Tranexamic Acid—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000141	0.000764	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00014	0.000762	CcSEcCtD
Tranexamic Acid—Fatigue—Metformin—type 2 diabetes mellitus	0.00014	0.000761	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.00014	0.00109	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00014	0.000759	CcSEcCtD
Tranexamic Acid—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000139	0.000758	CcSEcCtD
Tranexamic Acid—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000139	0.000757	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—ATF3—type 2 diabetes mellitus	0.000139	0.00109	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000139	0.00109	CbGpPWpGaD
Tranexamic Acid—Vomiting—Glyburide—type 2 diabetes mellitus	0.000138	0.000747	CcSEcCtD
Tranexamic Acid—Malaise—Ramipril—type 2 diabetes mellitus	0.000137	0.000743	CcSEcCtD
Tranexamic Acid—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000137	0.000743	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IGF1—type 2 diabetes mellitus	0.000137	0.00107	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT2—type 2 diabetes mellitus	0.000137	0.00107	CbGpPWpGaD
Tranexamic Acid—Headache—Glyburide—type 2 diabetes mellitus	0.000136	0.000736	CcSEcCtD
Tranexamic Acid—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000135	0.000734	CcSEcCtD
Tranexamic Acid—Hypotension—Losartan—type 2 diabetes mellitus	0.000135	0.000733	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—ICAM1—type 2 diabetes mellitus	0.000135	0.00105	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000134	0.000728	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000133	0.000724	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—NOS1—type 2 diabetes mellitus	0.000133	0.00104	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000133	0.000722	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000133	0.000722	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000132	0.000719	CcSEcCtD
Tranexamic Acid—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000132	0.000719	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000131	0.000715	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000131	0.000714	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000131	0.00103	CbGpPWpGaD
Tranexamic Acid—Convulsion—Ramipril—type 2 diabetes mellitus	0.000131	0.000714	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000131	0.00102	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000131	0.00102	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00013	0.000706	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SERPINE1—type 2 diabetes mellitus	0.00013	0.00101	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PTPN1—type 2 diabetes mellitus	0.00013	0.00101	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ALB—type 2 diabetes mellitus	0.00013	0.00101	CbGpPWpGaD
Tranexamic Acid—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000129	0.000702	CcSEcCtD
Tranexamic Acid—Chest pain—Ramipril—type 2 diabetes mellitus	0.000129	0.000702	CcSEcCtD
Tranexamic Acid—Myalgia—Ramipril—type 2 diabetes mellitus	0.000129	0.000702	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL6—type 2 diabetes mellitus	0.000129	0.00101	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000129	0.000699	CcSEcCtD
Tranexamic Acid—Nausea—Glyburide—type 2 diabetes mellitus	0.000128	0.000698	CcSEcCtD
Tranexamic Acid—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000128	0.000698	CcSEcCtD
Tranexamic Acid—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000128	0.000698	CcSEcCtD
Tranexamic Acid—Asthenia—Valsartan—type 2 diabetes mellitus	0.000128	0.000696	CcSEcCtD
Tranexamic Acid—Discomfort—Ramipril—type 2 diabetes mellitus	0.000128	0.000693	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—RASGRP1—type 2 diabetes mellitus	0.000127	0.000996	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000127	0.00069	CcSEcCtD
Tranexamic Acid—Asthenia—Orlistat—type 2 diabetes mellitus	0.000127	0.000688	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000126	0.000687	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000126	0.000986	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000126	0.000986	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000126	0.000985	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000125	0.000681	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—F7—type 2 diabetes mellitus	0.000125	0.000977	CbGpPWpGaD
Tranexamic Acid—Fatigue—Losartan—type 2 diabetes mellitus	0.000124	0.000676	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000124	0.000969	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3R1—type 2 diabetes mellitus	0.000124	0.000968	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000124	0.000967	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000124	0.000673	CcSEcCtD
Tranexamic Acid—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000124	0.000671	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000123	0.000958	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000122	0.000664	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—PAX6—type 2 diabetes mellitus	0.000122	0.000951	CbGpPWpGaD
Tranexamic Acid—Headache—Gliclazide—type 2 diabetes mellitus	0.000122	0.000661	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000121	0.00066	CcSEcCtD
Tranexamic Acid—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000121	0.000659	CcSEcCtD
Tranexamic Acid—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000121	0.000656	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000119	0.000646	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000118	0.000641	CcSEcCtD
Tranexamic Acid—Dizziness—Valsartan—type 2 diabetes mellitus	0.000118	0.000641	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000117	0.000914	CbGpPWpGaD
Tranexamic Acid—Dizziness—Orlistat—type 2 diabetes mellitus	0.000117	0.000634	CcSEcCtD
Tranexamic Acid—Asthenia—Metformin—type 2 diabetes mellitus	0.000117	0.000634	CcSEcCtD
Tranexamic Acid—Hypotension—Ramipril—type 2 diabetes mellitus	0.000116	0.000628	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—SOD1—type 2 diabetes mellitus	0.000116	0.000902	CbGpPWpGaD
Tranexamic Acid—Nausea—Gliclazide—type 2 diabetes mellitus	0.000115	0.000627	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000115	0.000895	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000114	0.00062	CcSEcCtD
Tranexamic Acid—Vomiting—Valsartan—type 2 diabetes mellitus	0.000113	0.000617	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000113	0.000614	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000113	0.000613	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—SERPINE1—type 2 diabetes mellitus	0.000113	0.000879	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000112	0.000876	CbGpPWpGaD
Tranexamic Acid—Vomiting—Orlistat—type 2 diabetes mellitus	0.000112	0.000609	CcSEcCtD
Tranexamic Acid—Headache—Valsartan—type 2 diabetes mellitus	0.000112	0.000608	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—GNB3—type 2 diabetes mellitus	0.000112	0.000873	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—GHRL—type 2 diabetes mellitus	0.000111	0.000871	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000111	0.000604	CcSEcCtD
Tranexamic Acid—Headache—Orlistat—type 2 diabetes mellitus	0.00011	0.0006	CcSEcCtD
Tranexamic Acid—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.00011	0.0006	CcSEcCtD
Tranexamic Acid—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00011	0.000598	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IGF2—type 2 diabetes mellitus	0.00011	0.000857	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000109	0.000592	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—ACE—type 2 diabetes mellitus	0.000108	0.000843	CbGpPWpGaD
Tranexamic Acid—Dizziness—Metformin—type 2 diabetes mellitus	0.000107	0.000584	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000107	0.000838	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000107	0.000837	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—SRC—type 2 diabetes mellitus	0.000107	0.000836	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000107	0.000835	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000107	0.000581	CcSEcCtD
Tranexamic Acid—Fatigue—Ramipril—type 2 diabetes mellitus	0.000107	0.00058	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—APOB—type 2 diabetes mellitus	0.000107	0.000832	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000106	0.000578	CcSEcCtD
Tranexamic Acid—Nausea—Valsartan—type 2 diabetes mellitus	0.000106	0.000576	CcSEcCtD
Tranexamic Acid—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000105	0.00057	CcSEcCtD
Tranexamic Acid—Nausea—Orlistat—type 2 diabetes mellitus	0.000105	0.000569	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	0.000104	0.00081	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000104	0.00081	CbGpPWpGaD
Tranexamic Acid—Asthenia—Losartan—type 2 diabetes mellitus	0.000104	0.000563	CcSEcCtD
Tranexamic Acid—Vomiting—Metformin—type 2 diabetes mellitus	0.000103	0.000561	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000102	0.000554	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—GCG—type 2 diabetes mellitus	0.000102	0.000797	CbGpPWpGaD
Tranexamic Acid—Headache—Metformin—type 2 diabetes mellitus	0.000102	0.000553	CcSEcCtD
Tranexamic Acid—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000101	0.000551	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000101	0.00055	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	9.94e-05	0.000776	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Losartan—type 2 diabetes mellitus	9.88e-05	0.000537	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GIPR—type 2 diabetes mellitus	9.84e-05	0.000769	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GRK5—type 2 diabetes mellitus	9.84e-05	0.000769	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Ramipril—type 2 diabetes mellitus	9.78e-05	0.000532	CcSEcCtD
Tranexamic Acid—Vomiting—Irbesartan—type 2 diabetes mellitus	9.75e-05	0.00053	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.67e-05	0.000755	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CD36—type 2 diabetes mellitus	9.66e-05	0.000755	CbGpPWpGaD
Tranexamic Acid—Nausea—Metformin—type 2 diabetes mellitus	9.65e-05	0.000525	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.62e-05	0.000752	CbGpPWpGaD
Tranexamic Acid—Headache—Irbesartan—type 2 diabetes mellitus	9.61e-05	0.000522	CcSEcCtD
Tranexamic Acid—Dizziness—Losartan—type 2 diabetes mellitus	9.54e-05	0.000519	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PPP2CA—type 2 diabetes mellitus	9.54e-05	0.000745	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.54e-05	0.000745	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—EGFR—type 2 diabetes mellitus	9.38e-05	0.000733	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.22e-05	0.00072	CbGpPWpGaD
Tranexamic Acid—Vomiting—Losartan—type 2 diabetes mellitus	9.18e-05	0.000499	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	9.16e-05	0.000716	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CASP3—type 2 diabetes mellitus	9.12e-05	0.000713	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Ramipril—type 2 diabetes mellitus	9.12e-05	0.000495	CcSEcCtD
Tranexamic Acid—Nausea—Irbesartan—type 2 diabetes mellitus	9.11e-05	0.000495	CcSEcCtD
Tranexamic Acid—Headache—Losartan—type 2 diabetes mellitus	9.04e-05	0.000491	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—MC4R—type 2 diabetes mellitus	9e-05	0.000703	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	8.93e-05	0.000697	CbGpPWpGaD
Tranexamic Acid—Asthenia—Ramipril—type 2 diabetes mellitus	8.88e-05	0.000483	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—MMP1—type 2 diabetes mellitus	8.81e-05	0.000688	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—GNB3—type 2 diabetes mellitus	8.79e-05	0.000687	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GIP—type 2 diabetes mellitus	8.66e-05	0.000677	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—IGF2—type 2 diabetes mellitus	8.63e-05	0.000674	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	8.62e-05	0.000674	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—MMP9—type 2 diabetes mellitus	8.62e-05	0.000674	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.62e-05	0.000673	CbGpPWpGaD
Tranexamic Acid—Nausea—Losartan—type 2 diabetes mellitus	8.57e-05	0.000466	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—CALM1—type 2 diabetes mellitus	8.55e-05	0.000668	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.47e-05	0.00046	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—APOA1—type 2 diabetes mellitus	8.43e-05	0.000658	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	8.23e-05	0.000643	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	8.23e-05	0.000643	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LEPR—type 2 diabetes mellitus	8.23e-05	0.000643	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	8.19e-05	0.00064	CbGpPWpGaD
Tranexamic Acid—Dizziness—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000445	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PRKCB—type 2 diabetes mellitus	8.04e-05	0.000628	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	8.04e-05	0.000628	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	7.99e-05	0.000624	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	7.94e-05	0.000621	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—NOS2—type 2 diabetes mellitus	7.94e-05	0.000621	CbGpPWpGaD
Tranexamic Acid—Vomiting—Ramipril—type 2 diabetes mellitus	7.87e-05	0.000428	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	7.86e-05	0.000614	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.78e-05	0.000608	CbGpPWpGaD
Tranexamic Acid—Headache—Ramipril—type 2 diabetes mellitus	7.75e-05	0.000421	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—TLE4—type 2 diabetes mellitus	7.65e-05	0.000598	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ADRB3—type 2 diabetes mellitus	7.36e-05	0.000575	CbGpPWpGaD
Tranexamic Acid—Nausea—Ramipril—type 2 diabetes mellitus	7.35e-05	0.000399	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.29e-05	0.00057	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—IL6—type 2 diabetes mellitus	7.21e-05	0.000563	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CRHR1—type 2 diabetes mellitus	7.11e-05	0.000556	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—TGFB1—type 2 diabetes mellitus	7.11e-05	0.000555	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IGF1—type 2 diabetes mellitus	7.04e-05	0.00055	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT2—type 2 diabetes mellitus	7.04e-05	0.00055	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	7e-05	0.000547	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MMP1—type 2 diabetes mellitus	6.93e-05	0.000541	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—AGT—type 2 diabetes mellitus	6.84e-05	0.000535	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—LEP—type 2 diabetes mellitus	6.71e-05	0.000524	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SERPINE1—type 2 diabetes mellitus	6.69e-05	0.000523	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	6.68e-05	0.000522	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ALB—type 2 diabetes mellitus	6.68e-05	0.000522	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—AKT1—type 2 diabetes mellitus	6.65e-05	0.00052	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	6.56e-05	0.000513	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	6.5e-05	0.000508	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SPRY2—type 2 diabetes mellitus	6.5e-05	0.000508	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	6.49e-05	0.000507	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	6.4e-05	0.0005	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3R1—type 2 diabetes mellitus	6.39e-05	0.000499	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—NOS3—type 2 diabetes mellitus	6.39e-05	0.000499	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RBP4—type 2 diabetes mellitus	6.34e-05	0.000495	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GLP1R—type 2 diabetes mellitus	6.34e-05	0.000495	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCKAR—type 2 diabetes mellitus	6.24e-05	0.000487	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.78e-05	0.000452	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—INS—type 2 diabetes mellitus	5.73e-05	0.000448	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	5.7e-05	0.000445	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.65e-05	0.000441	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CCL2—type 2 diabetes mellitus	5.64e-05	0.00044	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.61e-05	0.000439	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—INSR—type 2 diabetes mellitus	5.58e-05	0.000436	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—IGF1—type 2 diabetes mellitus	5.54e-05	0.000433	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	5.52e-05	0.000431	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	5.49e-05	0.000429	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TRPC6—type 2 diabetes mellitus	5.48e-05	0.000428	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AGTR2—type 2 diabetes mellitus	5.45e-05	0.000426	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	5.44e-05	0.000425	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	5.26e-05	0.000411	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.22e-05	0.000408	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.07e-05	0.000396	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.07e-05	0.000396	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.93e-05	0.000385	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.92e-05	0.000384	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.91e-05	0.000383	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.82e-05	0.000377	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.8e-05	0.000375	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.8e-05	0.000375	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.74e-05	0.000371	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SRC—type 2 diabetes mellitus	4.72e-05	0.000369	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VEGFA—type 2 diabetes mellitus	4.6e-05	0.000359	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.47e-05	0.000349	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.44e-05	0.000347	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GCG—type 2 diabetes mellitus	4.39e-05	0.000343	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.39e-05	0.000343	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.32e-05	0.000338	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.31e-05	0.000337	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TGFB1—type 2 diabetes mellitus	4.22e-05	0.00033	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.16e-05	0.000325	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.82e-05	0.000299	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.79e-05	0.000296	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AVP—type 2 diabetes mellitus	3.74e-05	0.000292	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.74e-05	0.000292	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.72e-05	0.000291	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.7e-05	0.000289	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APOB—type 2 diabetes mellitus	3.61e-05	0.000282	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.6e-05	0.000281	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.55e-05	0.000278	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LPL—type 2 diabetes mellitus	3.45e-05	0.000269	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.38e-05	0.000264	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.3e-05	0.000258	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.23e-05	0.000253	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.18e-05	0.000248	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—C3—type 2 diabetes mellitus	3.1e-05	0.000243	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.96e-05	0.000231	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.95e-05	0.000231	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AGT—type 2 diabetes mellitus	2.95e-05	0.00023	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—AKT1—type 2 diabetes mellitus	2.94e-05	0.000229	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.9e-05	0.000227	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LEP—type 2 diabetes mellitus	2.89e-05	0.000226	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APOE—type 2 diabetes mellitus	2.89e-05	0.000226	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.86e-05	0.000223	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.73e-05	0.000213	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.58e-05	0.000201	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—INS—type 2 diabetes mellitus	2.47e-05	0.000193	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.43e-05	0.00019	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.39e-05	0.000187	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.39e-05	0.000186	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.27e-05	0.000177	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.16e-05	0.000169	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.16e-05	0.000169	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RELA—type 2 diabetes mellitus	2.04e-05	0.000159	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.84e-05	0.000144	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.74e-05	0.000136	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.72e-05	0.000134	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SRC—type 2 diabetes mellitus	1.6e-05	0.000125	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.56e-05	0.000122	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.43e-05	0.000112	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.4e-05	0.00011	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6—type 2 diabetes mellitus	1.08e-05	8.43e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.95e-06	7.78e-05	CbGpPWpGaD
